Citation Impact
Citing Papers
Drug Resistance inMycobacterium tuberculosis
2006
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Epidemiology of Invasive Mycoses in North America
2010
Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review
2023 Standout
A solid-phase dot assay using silica/gold nanoshells
2006
Treatment of Refractory Coccidioidomycosis With Voriconazole or Posaconazole
2011
Effects of Living at Higher Altitudes on Mortality: A Narrative Review
2014
Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
2012 Standout
Identification of new components of the RipC-FtsEX cell separation pathway of Corynebacterineae
2019 StandoutNobel
SARS and MERS: recent insights into emerging coronaviruses
2016 Standout
Immunological biomarkers of tuberculosis
2011
Non-Opsonic Recognition of <i>Mycobacterium tuberculosis</i> by Phagocytes
2008
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice
2010
Mycetoma: a unique neglected tropical disease
2015
Deletion of Cg-emb in Corynebacterianeae Leads to a Novel Truncated Cell Wall Arabinogalactan, whereas Inactivation of Cg-ubiA Results in an Arabinan-deficient Mutant with a Cell Wall Galactan Core
2005
Posaconazole for Chronic Refractory Coccidioidal Meningitis
2011
Waves of resistance: Staphylococcus aureus in the antibiotic era
2009 Standout
Antituberculosis drugs: Ten years of research
2007
Candida albicanspathogenicity mechanisms
2013 Standout
Antibiotic resistance and its cost: is it possible to reverse resistance?
2010 Standout
Vertebral Coccidioidomycosis: Presentation and Multidisciplinary Management
2012
Neutrophil Extracellular Traps in Pulmonary Diseases: Too Much of a Good Thing?
2016
Tuberculosis control and elimination 2010–50: cure, care, and social development
2010 Standout
Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review
2018 Standout
Analysis of rpoB and pncA mutations in the published literature: an insight into the role of oxidative stress in Mycobacterium tuberculosis evolution?
2005
Posaconazole: a broad-spectrum triazole antifungal
2005
Sequential assembly of the septal cell envelope prior to V snapping in Corynebacterium glutamicum
2019 StandoutNobel
Posaconazole: A Broad-Spectrum Triazole Antifungal Agent
2007
Biomarkers in acute respiratory distress syndrome
2013
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
Coccidioidal Meningitis
2010
A paradigm for the evaluation and management of spinal coccidioidomycosis
2015
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Surgery for Pulmonary Coccidioidomycosis: A 10-Year Experience
2009
An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients
2010
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Biological Activities of Hydrazone Derivatives
2007 Standout
Antibiotics and Bacterial Resistance in the 21st Century
2014 Standout
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
2017 Standout
Conazoles
2010
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
In Vitro Activity of TR-700, the Antibacterial Moiety of the Prodrug TR-701, against Linezolid-Resistant Strains
2008
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Direct Visualization of the Outer Membrane of Mycobacteria and Corynebacteria in Their Native State
2008 StandoutNobel
The Immune Response in Tuberculosis
2013 Standout
Monofunctionalized Gold Nanoparticles Stabilized by a Single Dendrimer Form Dumbbell Structures upon Homocoupling
2012 StandoutNobel
Gold nanoparticles: preparation, functionalisation and applications in biochemistry and immunochemistry
2007
Point-of-Care Diagnostics for Global Health
2008 Standout
Posaconazole Exposure-Response Relationship: Evaluating the Utility of Therapeutic Drug Monitoring
2012
Facile bio-synthesis of gold nanoparticles by using extract of Hibiscus sabdariffa and evaluation of its cytotoxicity against U87 glioblastoma cells under hyperglycemic condition
2015 Standout
Natural product and natural product derived drugs in clinical trials
2014 Standout
Pipeline of Known Chemical Classes of Antibiotics
2013
The Public Health Impact of Coccidioidomycosis in Arizona and California
2011
Dumbbells, Trikes and Quads: Organic–Inorganic Hybrid Nanoarchitectures Based on “Clicked” Gold Nanoparticles
2013 StandoutNobel
Recent Advances in Our Understanding of the Environmental, Epidemiological, Immunological, and Clinical Dimensions of Coccidioidomycosis
2013
Wild-Type MIC Distributions and Epidemiological Cutoff Values for Posaconazole and Voriconazole and Candida spp. as Determined by 24-Hour CLSI Broth Microdilution
2010
Atomically Precise Clusters of Noble Metals: Emerging Link between Atoms and Nanoparticles
2017 Standout
Targeting Antibiotic Resistance
2016
Oxidative damage of SP-D abolishes control of eosinophil extracellular DNA trap formation
2018 StandoutNobel
Works of Adrián Rendón being referenced
Soluble RAGE as a severity marker in community acquired pneumonia associated sepsis
2012
Expression of CDllc in Blood Monocytes as Biomarker for Favorable Response to Antituberculosis Treatment
2009
Posaconazole Therapy for Chronic Refractory Coccidioidomycosis
2007
Relevant Cytokines in the Management of Community-Acquired Pneumonia
2016
Safety, Tolerance, and Efficacy of Posaconazole Therapy in Patients with Nonmeningeal Disseminated or Chronic Pulmonary Coccidioidomycosis
2007
CD14 C(−159)T Polymorphism Is a Risk Factor for Development of Pulmonary Tuberculosis
2007
Chronic obstructive pulmonary disease case finding in Mexico in an at-risk population
2011
Antineutrophil cytoplasm autoantibodies in patients with tuberculosis are directed against bactericidal/permeability increasing protein and are detected after treatment initiation.
2010
In Vitro Activities of DA-7157 and DA-7218 against Mycobacterium tuberculosis and Nocardia brasiliensis
2006
Dot Blot Assay for Detection of Antidiacyltrehalose Antibodies in Tuberculous Patients
1999
In Vitro Susceptibility of Mycobacterium tuberculosis Clinical Isolates to Garenoxacin and DA-7867
2005
Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico
2004